CRL Overview — StockExplainer

+41%

+3.5% per year

Past performance does not guarantee future results. The data presented is indicative and may not be updated in real-time.

Country US

Exchange NYSE

Industry Medical - Diagnostics & Research

Sector Healthcare

Market Cap $9.69B

CEO Mr. James C. Foster J.D.

Charles River Laboratories International, Inc. (CRL) helps companies develop new medicines and treatments. They provide important services like testing and safety checks for drugs before they reach patients. They also breed special lab animals, like mice and rats, which scientists use to study diseases and test new drugs. In simple terms, CRL supports the healthcare industry by making sure that new health products are safe and effective.

Streams of revenue

Discovery and Safety Assessment: 76%

Manufacturing Support: 24%

Geographic Distribution

UNITED STATES: 56%

Europe: 27%

CANADA: 13%

Asia Pacific: 5%

Core Products

🐁

Research Models Lab animal models

🧪

Biologics Testing Biologics analysis

🔍

Discovery Services Drug discovery

🦠

Microbial Solutions Microbial detection

🔬

Preclinical Services Drug safety testing

Business Type

Business to Business

Competitive Advantages

🌍

Global Reach With operations in multiple regions, CRL can serve a broad international client base, enhancing its market presence.

📜

Regulatory Expertise The company has deep knowledge of regulatory requirements, helping clients navigate complex compliance landscapes in drug development.

🏆

Established Reputation Charles River has built a strong reputation over decades, making it a trusted partner for pharmaceutical and biotechnology companies.

🔍

Diverse Service Offerings The company provides a wide range of integrated services across drug discovery and development, catering to various client needs.

🐭

Innovative Research Models CRL specializes in genetically engineered and purpose-bred research models, maintaining a competitive edge in non-clinical research.

Key Business Risks

🔗

Client Dependency High dependency on a limited number of large clients may pose financial risks if contracts are lost or reduced.

📉

Market Competition Intense competition in the contract research sector may pressure pricing and market share.

⚖️

Regulatory Compliance Non-compliance with evolving regulations can lead to fines, operational disruptions, and reputational damage.

🚧

Supply Chain Disruptions Disruptions in the supply chain for research models and materials can affect service delivery and client satisfaction.

💻

Technological Advancements Failure to keep pace with rapid technological changes can impact service offerings and operational efficiency.

Meeting Expectations

10 /10

Higher values indicate better execution and credibility

Business Overview

Performance Analysis

Stock Price

Performance Analysis

Stock Price